Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07536399 · ClinicalTrials.gov registry record · Phase 3
Biologic Augmentation of TMJ Arthroscopy Using BMAC
A Phase 3 study, sponsored by Weill Medical College of Cornell University.
- Not yet
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT07536399 is a Phase 3 study that has not yet begun recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 20 participants.
The verdict
NCT07536399, a Phase 3 study, has not yet begun recruiting, sponsored by Weill Medical College of Cornell University.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn about the efficacy of using Bone Marrow Aspirate Concentrate (BMAC) during temporomandibular joint (TMJ) arthroscopy compared to standard arthroscopic procedures with corticosteroid (CS) injections in patients with pain (arthralgia) of the temporomandibular joint (TMJ) that has failed to respond to conservative treatment. The main question it aims to answer: Does BMAC injection reduce the amount of inflammation and structural damage in the TMJ? Researchers will compare BMAC injection to corticosteroid injections see if BMAC injection helps . Participants will : * Be randomized to receive either BMAC or CS injection during TMJ arthroscopy * Visit the clinic for 3 follow up visits over 6 months and answer questionnaires * have 2 MRIs of their jaw
Interventions
- BIOLOGICAL Bone Marrow Aspirate Concentrate
- DRUG Corticosteroid (CS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-04 |
| Est. Completion | 2028-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07536399
The ClinicalTrials.gov registry entry for NCT07536399 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bone Marrow Aspirate Concentrate is the first listed.
NCT07536399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07536399 about?
NCT07536399 is a clinical study titled "Biologic Augmentation of TMJ Arthroscopy Using BMAC". The goal of this clinical trial is to learn about the efficacy of using Bone Marrow Aspirate Concentrate (BMAC) during temporomandibular joint (TMJ) arthroscopy compared to standard arthroscopic procedures with corticosteroid (CS) injections in patients with pain (arthralgia) of the temporomandibula...
What is the current status of trial NCT07536399?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2026-04. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07536399?
The interventions under investigation include: Bone Marrow Aspirate Concentrate (BIOLOGICAL), Corticosteroid (CS) (DRUG).
Who is sponsoring clinical trial NCT07536399?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.